Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy

by Tobias J. Pfeffer, Manuel List, Julia H. Müller, Michaela Scherr, Johann Bauersachs, Denise Hilfiker‐Kleiner, Melanie Ricke‐Hoch
Published 2021-08-01

Assessment of major mental disorders in a German peripartum cardiomyopathy cohort

by Tobias J. Pfeffer, Julian Herrmann, Dominik Berliner, Tobias König, Lotta Winter, Melanie Ricke‐Hoch, Evgeni Ponimaskin, Sven Schuchardt, Thomas Thum, Denise Hilfiker‐Kleiner, Johann Bauersachs, Kai G. Kahl
Published 2020-12-01

Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers

by Feriel Azibani, Tobias J. Pfeffer, Melanie Ricke‐Hoch, Wentzel Dowling, Stefan Pietzsch, Olivia Briton, Johann Baard, Valeska Abou Moulig, Tobias König, Dominik Berliner, Elena Libhaber, Stella Schlothauer, John Anthony, Ralf Lichtinghagen, Johann Bauersachs, Karen Sliwa, Denise Hilfiker‐Kleiner
Published 2020-04-01

Increased Cancer Prevalence in Peripartum Cardiomyopathy

by Tobias J. Pfeffer, MD, Stella Schlothauer, MS, Stefan Pietzsch, PhD, Maria Schaufelberger, MD, Bernd Auber, MD, Melanie Ricke-Hoch, PhD, Manuel List, MS, Dominik Berliner, MD, Valeska Abou Moulig, MD, Tobias König, MD, Zolt Arany, MD, PhD, Karen Sliwa, MD, Johann Bauersachs, MD, Denise Hilfiker-Kleiner, PhD
Published 2019-12-01

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease

by Melanie Ricke-Hoch, Elisabeth Stelling, Lisa Lasswitz, Antonia P. Gunesch, Martina Kasten, Francisco J. Zapatero-Belinchón, Graham Brogden, Gisa Gerold, Thomas Pietschmann, Virginie Montiel, Jean-Luc Balligand, Federica Facciotti, Emilio Hirsch, Thomas Gausepohl, Husni Elbahesh, Guus F. Rimmelzwaan, Anne Höfer, Mark P. Kühnel, Danny Jonigk, Julian Eigendorf, Uwe Tegtbur, Lena Mink, Michaela Scherr, Thomas Illig, Axel Schambach, Tobias J. Pfeffer, Andres Hilfiker, Axel Haverich, Denise Hilfiker-Kleiner
Published 2021-01-01

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease.

by Melanie Ricke-Hoch, Elisabeth Stelling, Lisa Lasswitz, Antonia P Gunesch, Martina Kasten, Francisco J Zapatero-Belinchón, Graham Brogden, Gisa Gerold, Thomas Pietschmann, Virginie Montiel, Jean-Luc Balligand, Federica Facciotti, Emilio Hirsch, Thomas Gausepohl, Husni Elbahesh, Guus F Rimmelzwaan, Anne Höfer, Mark P Kühnel, Danny Jonigk, Julian Eigendorf, Uwe Tegtbur, Lena Mink, Michaela Scherr, Thomas Illig, Axel Schambach, Tobias J Pfeffer, Andres Hilfiker, Axel Haverich, Denise Hilfiker-Kleiner
Published 2021-01-01